Get startedLog in
    Picture of Evofem Biosciences logo

    EVFM — Evofem Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: FDA Awards QIDP Designation For Prevention Of Chlamydia To Evofem Biosciences

    Picture of Evofem Biosciences logoEvofem Biosciences
    09/02/2022 14:13
    Feb 9 (Reuters) - Evofem Biosciences Inc  EVFM.O :
    * FDA AWARDS QIDP DESIGNATION FOR PREVENTION OF CHLAMYDIA TO
EVOFEM BIOSCIENCES
    * EVOFEM BIOSCIENCES INC - TOP-LINE DATA FROM EVOGUARD ARE
EXPECTED IN Q3 OF 2022
    * EVOFEM BIOSCIENCES INC - POSITIVE OUTCOMES FROM EVOGUARD
TRIAL
COULD SUPPORT SUBMISSION TO FDA FOR POTENTIAL NEW INDICATIONS IN
Q1 OF 2023

Source text for Eikon:  ID:nPn1HVL8Za 
Further company coverage:  EVFM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Evofem Biosciences

    See all news